HRT Financial’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q2
Sell
-24,092
Closed -$445K 3585
2022
Q1
$445K Buy
+24,092
New +$445K ﹤0.01% 1745